Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Bronchial Basal Cells for Bronchiectasis
NCT03655808Phase 2Completed
- Sponsor
- Ruijin Hospital
- Start
- Jun 2020
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in bronchiectasis, sponsored by Ruijin Hospital. Started Jun 2020; status: completed.
02
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT03655808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03655808.